摘要 : Melphalan has been a mainstay of multiple myeloma (MM) therapy for many years. However, following treatment with this alkylator, malignant plasma cells usually escape both apoptosis and cell cycle control, and acquire drug-resista... 展开
作者 | Cives~ M. Ciavarella~ S. Rizzo~ F.M. De Matteo~ M. Dammacco~ F. Silvestris~ F. |
---|---|
作者单位 | |
期刊名称 | 《Cellular Signalling》 |
总页数 | 10 |
语种/中图分类号 | 英语 / Q24 |
关键词 | Apoptosis Bendamustine Drug resistance Melphalan Mitotic catastrophe Multiple myeloma |
馆藏号 | N2008EPST0000615 |